190 related articles for article (PubMed ID: 12474368)
1. [Beta blockade plus NO release. Patients with heart failure can be loaded more].
MMW Fortschr Med; 2002 Oct; 144(41):57. PubMed ID: 12474368
[No Abstract] [Full Text] [Related]
2. [Beta blocker activates release of NO. Radical against atherosclerosis].
MMW Fortschr Med; 2004 Mar; 146(11):57. PubMed ID: 15152777
[No Abstract] [Full Text] [Related]
3. [Beta-1 blockade plus NO release. Additional organ protection for patients with hypertension].
MMW Fortschr Med; 2003 Oct; 145(40):57. PubMed ID: 14603611
[No Abstract] [Full Text] [Related]
4. Nebivolol: a new beta blocker on the horizon.
Katira R; Chauhan A
Indian Heart J; 2000; 52(1):86-8. PubMed ID: 10820942
[No Abstract] [Full Text] [Related]
5. [Initial data on nebivolol in heart failure. Beta blockers strengthen older hearts, too].
MMW Fortschr Med; 2003 May; 145(22):55. PubMed ID: 12866284
[No Abstract] [Full Text] [Related]
6. [Beta blocker improves the endothelial function. Gas-forming blood vessel protection].
MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974334
[No Abstract] [Full Text] [Related]
7. [Influence of the beta-blocker nebivolol on left ventricular function in patients with chronic heart failure].
Wolf SC; Buck-Müller N; Görner S; Risler T; Brehm BR
Med Klin (Munich); 2003 Jan; 98(1):1-6. PubMed ID: 12540987
[TBL] [Abstract][Full Text] [Related]
8. Nebivolol in older adults with heart failure: reduced rates for seniors?
Armstrong PW; Alexander KP
J Am Coll Cardiol; 2009 Jun; 53(23):2159-61. PubMed ID: 19497442
[No Abstract] [Full Text] [Related]
9. β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure.
Ambrosio G; Flather MD; Böhm M; Cohen-Solal A; Murrone A; Mascagni F; Spinucci G; Conti MG; van Veldhuisen DJ; Tavazzi L; Coats AJ
Heart; 2011 Feb; 97(3):209-14. PubMed ID: 21138861
[TBL] [Abstract][Full Text] [Related]
10. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
van Veldhuisen DJ; Cohen-Solal A; Böhm M; Anker SD; Babalis D; Roughton M; Coats AJ; Poole-Wilson PA; Flather MD;
J Am Coll Cardiol; 2009 Jun; 53(23):2150-8. PubMed ID: 19497441
[TBL] [Abstract][Full Text] [Related]
11. Nebivolol: a third-generation beta-blocker for hypertension.
Cheng JW
Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
[TBL] [Abstract][Full Text] [Related]
12. The role of the new beta-blockers in treating cardiovascular disease.
Weber MA
Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
[TBL] [Abstract][Full Text] [Related]
13. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
Brodde OE; Philipp T
Dtsch Med Wochenschr; 2006 Nov; 131(45):2545-50. PubMed ID: 17091442
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide mechanisms of nebivolol.
Maffei A; Lembo G
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
[TBL] [Abstract][Full Text] [Related]
15. [Effect of nebivolol on remodeling of the heart and vessels and the state of hemodynamics in patients with hypertension].
Gromnatskiĭ NI; Dius'mikeeva NB
Kardiologiia; 2002; 42(10):27-30. PubMed ID: 12494053
[TBL] [Abstract][Full Text] [Related]
16. Lack of sinus rhythm predicts readmission, not Beta blockade.
McCulloch AC
Am J Cardiol; 2010 May; 105(9):1358. PubMed ID: 20403494
[No Abstract] [Full Text] [Related]
17. [Comparison of effects of nebivolol and atenolol on P-wave dispersion in patients with hypertension].
Tuncer M; Fettser DV; Gunes Y; Batyraliev TA; Guntekin U; Gumrukchuoglu KhA; Eryonucu B; Guler N; Sidorenko BA
Kardiologiia; 2008; 48(4):42-5. PubMed ID: 18447840
[TBL] [Abstract][Full Text] [Related]
18. Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol.
Nodari S; Metra M; Dei Cas L
Eur J Heart Fail; 2003 Oct; 5(5):621-7. PubMed ID: 14607201
[TBL] [Abstract][Full Text] [Related]
19. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America.
Pharmacotherapy; 2000 May; 20(5):495-522. PubMed ID: 10809338
[No Abstract] [Full Text] [Related]
20. Nebivolol: new indication. Heart failure: 'me-too' available in single dose strength only. Select better-assessed betablockers.
Prescrire Int; 2007 Dec; 16(92):235. PubMed ID: 18087800
[No Abstract] [Full Text] [Related]
[Next] [New Search]